The appearance is white powder, CAS number is 87239-81-4, molecular formula is C21H27N5O9S2. It is suitable for infection of bronchitis, pneumonia and urinary system, skin and soft tissue, middle ear and tonsil caused by sensitive bacteria.

Market Analysis and Insights: Global Cefpodoxime Proxetil Market
The global Cefpodoxime Proxetil market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Cefpodoxime Proxetil Scope and Market Size
The global Cefpodoxime Proxetil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cefpodoxime Proxetil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Cefpodoxime Proxetil Tablets
Cefpodoxime Proxetil Capsule

The Cefpodoxime Proxetil market is analysed and market size information is provided by regions (countries). Segment by Application, the Cefpodoxime Proxetil market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
SPC Pharm
Jeil Pharmaceutical
Luoxin Pharmaceutical
Nishchem International
Dhanuka Laboratories
Reva Pharma
Orchid Pharma
Virchow Healthcare
Qilu Pharmaceutial
Guangzhou Pi & Pi Biotech
Athos Chemicals
Covalent Laboratories
Chemaxcel Corporation
Zhejiang Huafang Pharmaceutical
Canagen Pharmaceutical
RIC Chemicals